ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rotavirus Vaccines Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-7F2159
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Rotavirus Vaccines Market Insights and Forecast to 2028
BUY CHAPTERS

Global Rotavirus Vaccines Market Research Report 2025

Code: QYRE-Auto-7F2159
Report
September 2025
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bharat Biotech
Merck& Co. Inc
GlaxoSmithKline PLC
Lanzhou Institute of Biological
Bharat Biotech International Limited
Merck& Co. Inc

Rotavirus Vaccines Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Rotavirus Vaccines Market

Rotavirus Vaccines Market

The global market for Rotavirus Vaccines was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15–34% of severe diarrhea in the developing world and 37–96% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized.
The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, handwashing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age.
The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus.
The vaccine first became available in the United States in 2006. It is on the World Health Organization"s List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rotavirus Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rotavirus Vaccines.
The Rotavirus Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rotavirus Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rotavirus Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Rotavirus Vaccines Market Report

Report Metric Details
Report Name Rotavirus Vaccines Market
CAGR 5%
Segment by Type
  • Rotarix
  • RotaTeq
  • Rotavac
  • Rotavin-M1
  • Lanzhou lamb
  • Others
Segment by Application
  • Adult
  • Pediatric
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bharat Biotech, Merck & Co., Inc, GlaxoSmithKline plc, Lanzhou Institute of Biological, Bharat Biotech International Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Rotavirus Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Rotavirus Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Rotavirus Vaccines Market report?

Ans: The main players in the Rotavirus Vaccines Market are Bharat Biotech, Merck & Co., Inc, GlaxoSmithKline plc, Lanzhou Institute of Biological, Bharat Biotech International Limited

What are the Application segmentation covered in the Rotavirus Vaccines Market report?

Ans: The Applications covered in the Rotavirus Vaccines Market report are Adult, Pediatric

What are the Type segmentation covered in the Rotavirus Vaccines Market report?

Ans: The Types covered in the Rotavirus Vaccines Market report are Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Others

Recommended Reports

Pediatric Vaccines

Virus Vaccines

Immunity & Flu

1 Rotavirus Vaccines Market Overview
1.1 Product Definition
1.2 Rotavirus Vaccines by Type
1.2.1 Global Rotavirus Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Rotarix
1.2.3 RotaTeq
1.2.4 Rotavac
1.2.5 Rotavin-M1
1.2.6 Lanzhou lamb
1.2.7 Others
1.3 Rotavirus Vaccines by Application
1.3.1 Global Rotavirus Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Adult
1.3.3 Pediatric
1.4 Global Rotavirus Vaccines Market Size Estimates and Forecasts
1.4.1 Global Rotavirus Vaccines Revenue 2020-2031
1.4.2 Global Rotavirus Vaccines Sales 2020-2031
1.4.3 Global Rotavirus Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Rotavirus Vaccines Market Competition by Manufacturers
2.1 Global Rotavirus Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Rotavirus Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Rotavirus Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Rotavirus Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rotavirus Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rotavirus Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Rotavirus Vaccines, Date of Enter into This Industry
2.8 Global Rotavirus Vaccines Market Competitive Situation and Trends
2.8.1 Global Rotavirus Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Rotavirus Vaccines Players Market Share by Revenue
2.8.3 Global Rotavirus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Rotavirus Vaccines Market Scenario by Region
3.1 Global Rotavirus Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Rotavirus Vaccines Sales by Region: 2020-2031
3.2.1 Global Rotavirus Vaccines Sales by Region: 2020-2025
3.2.2 Global Rotavirus Vaccines Sales by Region: 2026-2031
3.3 Global Rotavirus Vaccines Revenue by Region: 2020-2031
3.3.1 Global Rotavirus Vaccines Revenue by Region: 2020-2025
3.3.2 Global Rotavirus Vaccines Revenue by Region: 2026-2031
3.4 North America Rotavirus Vaccines Market Facts & Figures by Country
3.4.1 North America Rotavirus Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Rotavirus Vaccines Sales by Country (2020-2031)
3.4.3 North America Rotavirus Vaccines Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Rotavirus Vaccines Market Facts & Figures by Country
3.5.1 Europe Rotavirus Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Rotavirus Vaccines Sales by Country (2020-2031)
3.5.3 Europe Rotavirus Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rotavirus Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Rotavirus Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Rotavirus Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Rotavirus Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Rotavirus Vaccines Market Facts & Figures by Country
3.7.1 Latin America Rotavirus Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Rotavirus Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Rotavirus Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rotavirus Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Rotavirus Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Rotavirus Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Rotavirus Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rotavirus Vaccines Sales by Type (2020-2031)
4.1.1 Global Rotavirus Vaccines Sales by Type (2020-2025)
4.1.2 Global Rotavirus Vaccines Sales by Type (2026-2031)
4.1.3 Global Rotavirus Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Rotavirus Vaccines Revenue by Type (2020-2031)
4.2.1 Global Rotavirus Vaccines Revenue by Type (2020-2025)
4.2.2 Global Rotavirus Vaccines Revenue by Type (2026-2031)
4.2.3 Global Rotavirus Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Rotavirus Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Rotavirus Vaccines Sales by Application (2020-2031)
5.1.1 Global Rotavirus Vaccines Sales by Application (2020-2025)
5.1.2 Global Rotavirus Vaccines Sales by Application (2026-2031)
5.1.3 Global Rotavirus Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Rotavirus Vaccines Revenue by Application (2020-2031)
5.2.1 Global Rotavirus Vaccines Revenue by Application (2020-2025)
5.2.2 Global Rotavirus Vaccines Revenue by Application (2026-2031)
5.2.3 Global Rotavirus Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Rotavirus Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bharat Biotech
6.1.1 Bharat Biotech Company Information
6.1.2 Bharat Biotech Description and Business Overview
6.1.3 Bharat Biotech Rotavirus Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bharat Biotech Rotavirus Vaccines Product Portfolio
6.1.5 Bharat Biotech Recent Developments/Updates
6.2 Merck & Co., Inc
6.2.1 Merck & Co., Inc Company Information
6.2.2 Merck & Co., Inc Description and Business Overview
6.2.3 Merck & Co., Inc Rotavirus Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck & Co., Inc Rotavirus Vaccines Product Portfolio
6.2.5 Merck & Co., Inc Recent Developments/Updates
6.3 GlaxoSmithKline plc
6.3.1 GlaxoSmithKline plc Company Information
6.3.2 GlaxoSmithKline plc Description and Business Overview
6.3.3 GlaxoSmithKline plc Rotavirus Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline plc Rotavirus Vaccines Product Portfolio
6.3.5 GlaxoSmithKline plc Recent Developments/Updates
6.4 Lanzhou Institute of Biological
6.4.1 Lanzhou Institute of Biological Company Information
6.4.2 Lanzhou Institute of Biological Description and Business Overview
6.4.3 Lanzhou Institute of Biological Rotavirus Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lanzhou Institute of Biological Rotavirus Vaccines Product Portfolio
6.4.5 Lanzhou Institute of Biological Recent Developments/Updates
6.5 Bharat Biotech International Limited
6.5.1 Bharat Biotech International Limited Company Information
6.5.2 Bharat Biotech International Limited Description and Business Overview
6.5.3 Bharat Biotech International Limited Rotavirus Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bharat Biotech International Limited Rotavirus Vaccines Product Portfolio
6.5.5 Bharat Biotech International Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rotavirus Vaccines Industry Chain Analysis
7.2 Rotavirus Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rotavirus Vaccines Production Mode & Process Analysis
7.4 Rotavirus Vaccines Sales and Marketing
7.4.1 Rotavirus Vaccines Sales Channels
7.4.2 Rotavirus Vaccines Distributors
7.5 Rotavirus Vaccines Customer Analysis
8 Rotavirus Vaccines Market Dynamics
8.1 Rotavirus Vaccines Industry Trends
8.2 Rotavirus Vaccines Market Drivers
8.3 Rotavirus Vaccines Market Challenges
8.4 Rotavirus Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bharat Biotech
Merck& Co. Inc
GlaxoSmithKline PLC
Lanzhou Institute of Biological
Bharat Biotech International Limited
Merck& Co. Inc
List of Tables
 Table 1. Global Rotavirus Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Rotavirus Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Rotavirus Vaccines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Rotavirus Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Rotavirus Vaccines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Rotavirus Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Rotavirus Vaccines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Rotavirus Vaccines Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Rotavirus Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Rotavirus Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Rotavirus Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Rotavirus Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Rotavirus Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rotavirus Vaccines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Rotavirus Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Rotavirus Vaccines Sales by Region (2020-2025) & (K Units)
 Table 18. Global Rotavirus Vaccines Sales Market Share by Region (2020-2025)
 Table 19. Global Rotavirus Vaccines Sales by Region (2026-2031) & (K Units)
 Table 20. Global Rotavirus Vaccines Sales Market Share by Region (2026-2031)
 Table 21. Global Rotavirus Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Rotavirus Vaccines Revenue Market Share by Region (2020-2025)
 Table 23. Global Rotavirus Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Rotavirus Vaccines Revenue Market Share by Region (2026-2031)
 Table 25. North America Rotavirus Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Rotavirus Vaccines Sales by Country (2020-2025) & (K Units)
 Table 27. North America Rotavirus Vaccines Sales by Country (2026-2031) & (K Units)
 Table 28. North America Rotavirus Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Rotavirus Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Rotavirus Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Rotavirus Vaccines Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Rotavirus Vaccines Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Rotavirus Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Rotavirus Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Rotavirus Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Rotavirus Vaccines Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Rotavirus Vaccines Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Rotavirus Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Rotavirus Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Rotavirus Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Rotavirus Vaccines Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Rotavirus Vaccines Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Rotavirus Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Rotavirus Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Rotavirus Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Rotavirus Vaccines Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Rotavirus Vaccines Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Rotavirus Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Rotavirus Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Rotavirus Vaccines Sales (K Units) by Type (2020-2025)
 Table 51. Global Rotavirus Vaccines Sales (K Units) by Type (2026-2031)
 Table 52. Global Rotavirus Vaccines Sales Market Share by Type (2020-2025)
 Table 53. Global Rotavirus Vaccines Sales Market Share by Type (2026-2031)
 Table 54. Global Rotavirus Vaccines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Rotavirus Vaccines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Rotavirus Vaccines Revenue Market Share by Type (2020-2025)
 Table 57. Global Rotavirus Vaccines Revenue Market Share by Type (2026-2031)
 Table 58. Global Rotavirus Vaccines Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Rotavirus Vaccines Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Rotavirus Vaccines Sales (K Units) by Application (2020-2025)
 Table 61. Global Rotavirus Vaccines Sales (K Units) by Application (2026-2031)
 Table 62. Global Rotavirus Vaccines Sales Market Share by Application (2020-2025)
 Table 63. Global Rotavirus Vaccines Sales Market Share by Application (2026-2031)
 Table 64. Global Rotavirus Vaccines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Rotavirus Vaccines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Rotavirus Vaccines Revenue Market Share by Application (2020-2025)
 Table 67. Global Rotavirus Vaccines Revenue Market Share by Application (2026-2031)
 Table 68. Global Rotavirus Vaccines Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Rotavirus Vaccines Price (USD/Unit) by Application (2026-2031)
 Table 70. Bharat Biotech Company Information
 Table 71. Bharat Biotech Description and Business Overview
 Table 72. Bharat Biotech Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Bharat Biotech Rotavirus Vaccines Product
 Table 74. Bharat Biotech Recent Developments/Updates
 Table 75. Merck & Co., Inc Company Information
 Table 76. Merck & Co., Inc Description and Business Overview
 Table 77. Merck & Co., Inc Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Merck & Co., Inc Rotavirus Vaccines Product
 Table 79. Merck & Co., Inc Recent Developments/Updates
 Table 80. GlaxoSmithKline plc Company Information
 Table 81. GlaxoSmithKline plc Description and Business Overview
 Table 82. GlaxoSmithKline plc Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. GlaxoSmithKline plc Rotavirus Vaccines Product
 Table 84. GlaxoSmithKline plc Recent Developments/Updates
 Table 85. Lanzhou Institute of Biological Company Information
 Table 86. Lanzhou Institute of Biological Description and Business Overview
 Table 87. Lanzhou Institute of Biological Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Lanzhou Institute of Biological Rotavirus Vaccines Product
 Table 89. Lanzhou Institute of Biological Recent Developments/Updates
 Table 90. Bharat Biotech International Limited Company Information
 Table 91. Bharat Biotech International Limited Description and Business Overview
 Table 92. Bharat Biotech International Limited Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Bharat Biotech International Limited Rotavirus Vaccines Product
 Table 94. Bharat Biotech International Limited Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Rotavirus Vaccines Distributors List
 Table 98. Rotavirus Vaccines Customers List
 Table 99. Rotavirus Vaccines Market Trends
 Table 100. Rotavirus Vaccines Market Drivers
 Table 101. Rotavirus Vaccines Market Challenges
 Table 102. Rotavirus Vaccines Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Rotavirus Vaccines
 Figure 2. Global Rotavirus Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Rotavirus Vaccines Market Share by Type: 2024 & 2031
 Figure 4. Rotarix Product Picture
 Figure 5. RotaTeq Product Picture
 Figure 6. Rotavac Product Picture
 Figure 7. Rotavin-M1 Product Picture
 Figure 8. Lanzhou lamb Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Rotavirus Vaccines Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Rotavirus Vaccines Market Share by Application: 2024 & 2031
 Figure 12. Adult
 Figure 13. Pediatric
 Figure 14. Global Rotavirus Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Rotavirus Vaccines Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Rotavirus Vaccines Sales (2020-2031) & (K Units)
 Figure 17. Global Rotavirus Vaccines Average Price (USD/Unit) & (2020-2031)
 Figure 18. Rotavirus Vaccines Report Years Considered
 Figure 19. Rotavirus Vaccines Sales Share by Manufacturers in 2024
 Figure 20. Global Rotavirus Vaccines Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Rotavirus Vaccines Players: Market Share by Revenue in Rotavirus Vaccines in 2024
 Figure 22. Rotavirus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Rotavirus Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Rotavirus Vaccines Sales Market Share by Country (2020-2031)
 Figure 25. North America Rotavirus Vaccines Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Rotavirus Vaccines Sales Market Share by Country (2020-2031)
 Figure 29. Europe Rotavirus Vaccines Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Rotavirus Vaccines Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Rotavirus Vaccines Revenue Market Share by Region (2020-2031)
 Figure 37. China Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Rotavirus Vaccines Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Rotavirus Vaccines Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Rotavirus Vaccines Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Rotavirus Vaccines Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Rotavirus Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Rotavirus Vaccines by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Rotavirus Vaccines by Type (2020-2031)
 Figure 59. Global Rotavirus Vaccines Price (USD/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Rotavirus Vaccines by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Rotavirus Vaccines by Application (2020-2031)
 Figure 62. Global Rotavirus Vaccines Price (USD/Unit) by Application (2020-2031)
 Figure 63. Rotavirus Vaccines Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Rotavirus Vaccine Market Research Report 2024
Oral Rotavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Multivalent Oral Rotavirus Vaccine Market Research Report 2024
Bovine Rotavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Live Attenuated Rotavirus Vaccine Market Research Report 2024
Global Live Attenuated Rotavirus Vaccine Market Research Report 2024
Polio Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cholera Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rotavirus Infection Therapeutics Market Research Report 2024
Global Poliomycetes Vaccine Market Insights Forecast to 2030
Global DTaP and Tdap Vaccines Market Insights Forecast to 2030
Global Hepatitis B Vaccination Market Research Report 2025
Hepatitis B Vaccines Market
Global Rotavirus Infections Drug Market Research Report 2024
Global Vaccines For Children Market Insights Forecast to 2030
Global Poliomyelitis Vaccine Market Research Report 2025
Swine Transmissble Gastroenteritis Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Polio Vaccination Market Research Report 2025
Mono Hepatitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions